Live Breaking News & Updates on Autologous Cancer Vaccine

Stay updated with breaking news from Autologous cancer vaccine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Torigen Pharmaceuticals Opens New Headquarters and Promotes Two to Executive Leadership

Farmington, CT (PRWEB) April 25, 2023 Torigen Pharmaceuticals Inc., a commercial-stage animal health biologics company that recently completed its Series A ....

United States , University Of Connecticut , Bryan Clauson , Ashley Kalinauskas , Troy Gobbett , Leadership Team , Business Development Managers , Torigen Team Growth , Torigen Pharmaceuticals Inc , University Of Notre Dame , Emerald Development Managers , Pharmaceuticals Inc , Executive Leadership Team , Vice President , Team Growth , Equine Sales , Senior Scientist , Corporate Accounts , Executive Sales , Executive Leadership , Operational Excellence , Chief Innovation Officer , Notre Dame , Sogal Ventures , Connecticut Innovations , Aimers Venture Partners ,

Torigen Pharmaceuticals and Veterinary Management Groups Enter into Preferred Partner Agreement

Farmington, CT (PRWEB) April 13, 2023 Torigen Pharmaceuticals, Inc (Farmington, CT), an animal health biologics company, today announced it has entered ....

University Of Connecticut , United States , Matthew Salois , Ashley Kalinauskas , Torigen Pharmaceuticals Inc Farmington , University Of Notre Dame , Emerald Development Managers , Founder Of Torigen Pharmaceuticals , Werth Family Investment Associates , Torigen Pharmaceuticals Inc , Preferred Partner Agreement , Veterinary Management Groups , General Practitioners , Autologous Cancer Vaccine , Veterinary Biologics , Notre Dame , Connecticut Innovations , Ironwood Capital , Advantage Capital , Sogal Ventures , Management Groups , Press Release ,

Torigen Pharmaceuticals and VerticalVet Enter into Preferred Partnership

Farmington, CT (PRWEB) December 08, 2022 Farmington, CT – DATE – Torigen Pharmaceuticals, Inc (Farmington, CT), an animal health biologics company, ....

University Of Connecticut , United States , John Wagoner , Hank Swartz , Ashley Kalinauskas , Werth Family Investment Associates , Veterinary Services , Torigen Pharmaceuticals Inc Farmington , Torigen Pharmaceuticals Inc , Group Purchasing Organization , Partnership Agreement , Emerald Development Managers , Vimians Group , University Of Notre Dame , Group Resource Community , Founder Of Torigen Pharmaceuticals , Preferred Partnership Agreement , Experimental Autologous Prescription , General Practitioners , Bernie Ward , Chief Veterinary Officer , Autologous Cancer Vaccine , Veterinary Biologics , Notre Dame , Connecticut Innovations , Ironwood Capital ,

Torigen Pharmaceuticals Inks National Distribution Deal with MWI Animal Health

Farmington, CT (PRWEB) June 22, 2022 Torigen Pharmaceuticals, Inc, a commercial-stage animal health biologics company, announced today that it has entered ....

University Of Connecticut , United States , Sean Fitzgerald , Ashley Kalinauskas , Market Development , Torigen Pharmaceuticals Inc , University Of Notre Dame , Emerald Development Partners , Animal Health , Founder Of Torigen Pharmaceuticals , Veterinary Biologics , Vice President , Steve Shell , Autologous Cancer Vaccine , Notre Dame , Werth Ventures , Connecticut Innovations , Sogal Ventures , Press Release ,

Torigen Expands Histopathology Services Through Strategic Partnership with Vidium Animal Health

Farmington, CT (PRWEB) April 27, 2022 Torigen Pharmaceuticals, Inc, a commercial-stage animal health biologics company, today announced it has entered into ....

University Of Connecticut , United States , Derick Whitley , Ashley Kalinauskas , Werth Family Investment Associates , Vidium Animal Health , Translational Genomics Research Institute Tgen , Torigen Pharmaceuticals , Torigen Pharmaceuticals Inc , University Of Notre Dame , Emerald Development Partners , Vidium Animal Health Vice , Animal Health , Vidium Animal Health Vice President , Autologous Cancer Vaccine , Veterinary Biologics , Notre Dame , Connecticut Innovations , Sogal Ventures , Translational Genomics Research Institute , Press Release ,